The cheapest nicotine-replacement drugs (NREPs) on the market, such as Lorillard’s Ego, are not meant to replace tobacco cigarettes, but to replace a person’s nicotine intake.
This has meant they are often more expensive than the cheaper NRTs.
The cheapest NREPs have a cost of about $13 per pack.
A cheaper alternative to the cheaper generic NREP, which has a cost between $5 and $10, is called naltrexone.
However, the cost of naltoxone has increased since its introduction in 2015.
The new research by the University of Sydney looked at how many NREPS and NREV-A drugs there are in the Australian market.
A pill is one of several NREs and is a generic name for a drug which is also used in the NHS and other healthcare facilities.
The researchers analysed the price data for all the generic NRT medications available in Australia from April to June 2017.
Their findings were published in the Journal of Clinical Pharmacology.
A generic NTR is a drug that has been specially made for a specific purpose.
It is often used to treat cancer and HIV patients.
This is often the case with generic drugs because they have not been tested to be safe and effective for a particular population, and therefore cannot be used in all circumstances.
The cost of a generic NR varies from $15 to $20 per pill.
“Generic NRE drugs have become so cheap that the average consumer does not see a benefit of them in the long run,” Professor Rolfo Rizzi from the School of Pharmacy said.
“This means that when a generic has become so expensive, people are buying them for convenience, but in the short term there is no benefit.”
The researchers looked at the generic prices of several generic NrePs, including naltronone (N-acetyl-2-cyanoate), naltriptan (N-(3-hydroxy-5-nitrobenzo-piperidin-2)) and naltriquel (N-[3-methyl-1-(2,5-dimethoxy)ethyl]-1-methylbenzamide), and their cheaper generic equivalents.
They compared these generic prices with the prices of the cheaper versions.
Professor Rizza said it was important to understand the cost-effectiveness of a NRE before buying it.
“The cost-benefit analysis shows that the generic is cheaper than the generic version, but it’s only one drug in a whole class of NRE products,” he said.
The Australian Bureau of Statistics (ABS) publishes drug prices in Australia each month.
“For a given generic, the most common cost of drug in the first quarter of 2018 was $20.05,” Professor Joo said.
In total, the ABS estimates there were 1,936 generic N-acetazolamide drugs and 1,890 generic N-[3,5-(2-chloroethyl)-2-methyl]1-butanone drugs in the market.
These drugs cost an average of $11.15 per pill in 2018.